Betulinic acid attenuates methotrexate nephrotoxicity by reducing oxidative stress and the expression of TLR4/NF-κB signaling pathway
Reports of Biochemistry and Molecular Biology · 2025
DOI: 10.66224/rbmb.14.2.271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reports of Biochemistry and Molecular Biology, 2025. Verfasst von Mehrnoush Matin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Methotrexate (MTX) is a medication widely used in the treatment of various conditions, including cancer. One potential side effect of MTX is nephrotoxicity. The purpose of the present study was to evaluate the effects of betulinic acid (BA) on MTX-induced nephrotoxicity in mice through the TLR4/NF-κB signaling pathway.
Methods
Four groups– control, BA 25 mg/kg, MTX 20 mg/kg, and BA+MTX- were considered for seven days to evaluate the effect of BA on MTX nephrotoxicity. Factors such as blood urea nitrogen (BUN ) , serum creatinine, antioxidant enzymes, oxidative stress markers, and pro-inflammatory cytokines were investigated. Toll-like receptor 4 (TLR4) and nuclear factor-kappa B (NF-κB) expression levels were measured using Western blot analysis.
Results
BUN and creatinine serum levels were significantly reduced in the BA-treated group compared to the MTX group. Furthermore, BA administration inhibited the activation of the TLR4/NF-κB signaling pathway, resulting in reduced expression of TLR4 and NF-κB. This decreased the release of pro-inflammatory cytokines linked to kidney inflammation, such as interleukin-1β and tumor necrosis factor-alpha. Moreover, BA exhibited notable antioxidant properties by enhancing the activity of enzymes like catalase, superoxide dismutase, and glutathione peroxidase. This antioxidant effect was evident by decreasing the levels of oxidative stress markers, as measured by the lipid peroxidation assay, and increasing the total thiol level.
Conclusion
These findings suggest that BA can ameliorate MTX-induced nephrotoxicity by reducing oxidative stress and enhancing the antioxidant defense system. It effectively reduces renal damage, inflammation, and oxidative stress. Our results demonstrate that BA's anti-inflammatory and antioxidant qualities could protect the kidneys from MTX's nephrotoxic effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Zitieren
APA
Matin, M., Khodayar, M. J., Mansouri, E., Etehadi, Y., & Moosavi, M. (2025). Betulinic acid attenuates methotrexate nephrotoxicity by reducing oxidative stress and the expression of TLR4/NF-κB signaling pathway. Reports of Biochemistry and Molecular Biology. https://doi.org/10.66224/rbmb.14.2.271
Vancouver
Matin M, Khodayar MJ, Mansouri E, Etehadi Y, Moosavi M. Betulinic acid attenuates methotrexate nephrotoxicity by reducing oxidative stress and the expression of TLR4/NF-κB signaling pathway. Reports of Biochemistry and Molecular Biology. 2025. doi:10.66224/rbmb.14.2.271
BibTeX
@article{Matin2025,
author = {Matin, Mehrnoush and Khodayar, Mohammad Javad and Mansouri, Esrafil and Etehadi, Yasin and Moosavi, Mehrnoosh},
title = {Betulinic acid attenuates methotrexate nephrotoxicity by reducing oxidative stress and the expression of TLR4/NF-κB signaling pathway},
journal = {Reports of Biochemistry and Molecular Biology},
year = {2025},
doi = {10.66224/rbmb.14.2.271}
}
EUVIMED